Global Dental Caries Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
The scientific term dental caries is known for the tooth decay or cavities. Tooth decays are generally caused by the specific endogenous bacteria such as Streptococcus mutans and Streptococcus sobrinus. Dental Caries occurs by the production of acid that later destroys the layer and enamel of the tooth. The bacteria continues to grow to produce acid that gets into the inner layer of the tooth if the decay is not removed on time. In the U.S, approximately 90% young adults suffering with dental caries, and out of all dentate adults approximately 94% suffer from coronal caries. According to the estimation of WHO, on a global basis, 200,335,280 teeth were either having decays decayed, filled or missing among the age group.
Growth of the dental caries treatment market is due to increase in sugar-based medication and lifestyle changes. According to World Health Organization (WHO), the cases of dental caries are declining due to increase in awareness and growing self-health care in the developed countries. The increase in number of dental awareness is one of the latest trends increasing dental caries treatment market are the hampering the dental caries market. The increase in caries commonly occurs in the children, lower socioeconomic group, and the new immigrants.
Dental Caries Treatment Market is segmented on the basis of product type, drug class, end-user and geography
On the basis of product type, dental caries treatment market is segmented as:
Based on geographical regions, dental caries market is segmented as five key regions: Latin America, North America, Asia Pacific, Europe, and Middle East & Africa. Currently, North America expected to contribute more for dental caries treatment market due to prevalence rates of dental caries. According to World Health Organization (WHO), in North America 90% of the people are diagnosed with dental caries. Factors such as lack of knowledge and lack of awareness among people about the prevention will hamper the market growth in regions like Asia-pacific.
Some of the market players in the dental caries treatment market includes Sanofi (France), Abbott Laboratories (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Merck & Co, Inc. (U.S.), AstraZeneca Plc. (U.S.), Dr.Reddy’s Lab (India), Novartis AG. (Switzerland), Dentsply Sirona Inc. (U.S.), 3M Company (U.S.), Danaher Corporation (U.S.), Zimmer Inc., (U.S.), Straumann AG (Switzerland), and Henry-Schein Inc. (U.S.) to name a few.
In 2017, Neocis Inc received U.S. FDA approval to market Yomi, robotic guide for dental implants
In 2016, Dental Evolutions Inc. introduced Implanova system the first self-grafting, and self-osteomizing dental implant system
In 2008, Manhattan Scientifics and Albuquerque, N.M. received U.S. FDA approval for its super strong titanium metal dental implant
REPORT OUTLINE:
Growth of the dental caries treatment market is due to increase in sugar-based medication and lifestyle changes. According to World Health Organization (WHO), the cases of dental caries are declining due to increase in awareness and growing self-health care in the developed countries. The increase in number of dental awareness is one of the latest trends increasing dental caries treatment market are the hampering the dental caries market. The increase in caries commonly occurs in the children, lower socioeconomic group, and the new immigrants.
Dental Caries Treatment Market is segmented on the basis of product type, drug class, end-user and geography
On the basis of product type, dental caries treatment market is segmented as:
- Dental Restoration
- Indirect Restoration
- Direct Restoration
- Dental Reconstruction
- Dentures
- Implants
- Abutments
- Crowns
- Bridges
- Endodontic
- Permanent Sealers
- Files
- Obturator Devices
- Others
- Infection Control
- Antimicrobial Peptides
- Expectorants
- Probiotics
- Oral Corticosteroids
- Hospitals
- Clinics
Based on geographical regions, dental caries market is segmented as five key regions: Latin America, North America, Asia Pacific, Europe, and Middle East & Africa. Currently, North America expected to contribute more for dental caries treatment market due to prevalence rates of dental caries. According to World Health Organization (WHO), in North America 90% of the people are diagnosed with dental caries. Factors such as lack of knowledge and lack of awareness among people about the prevention will hamper the market growth in regions like Asia-pacific.
Some of the market players in the dental caries treatment market includes Sanofi (France), Abbott Laboratories (U.S.), Bayer AG (Germany), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Merck & Co, Inc. (U.S.), AstraZeneca Plc. (U.S.), Dr.Reddy’s Lab (India), Novartis AG. (Switzerland), Dentsply Sirona Inc. (U.S.), 3M Company (U.S.), Danaher Corporation (U.S.), Zimmer Inc., (U.S.), Straumann AG (Switzerland), and Henry-Schein Inc. (U.S.) to name a few.
In 2017, Neocis Inc received U.S. FDA approval to market Yomi, robotic guide for dental implants
In 2016, Dental Evolutions Inc. introduced Implanova system the first self-grafting, and self-osteomizing dental implant system
In 2008, Manhattan Scientifics and Albuquerque, N.M. received U.S. FDA approval for its super strong titanium metal dental implant
REPORT OUTLINE:
- The report provides granular level information about the market size, regional market share and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
1. EXECUTIVE SUMMARY
2. GLOBAL DENTAL CARIES TREATMENT MARKET INTRODUCTION
2.1. Global Dental Caries Treatment Market– Taxonomy
2.2. Global Dental Caries Treatment Market–Definitions
2.2.1. Product Type
2.2.2. Drug Class
3. GLOBAL DENTAL CARIES TREATMENT MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dental Caries Treatment Market Dynamics – Factors Impact Analysis
3.6. Global Dental Caries Treatment Market– Recent Market Introductions
4. GLOBAL DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL DENTAL CARIES TREATMENT MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Dental Restoration
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Dental Reconstruction
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Endodontic
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. GLOBAL DENTAL CARIES TREATMENT MARKET FORECAST, BY DRUG CLASS, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Antimicrobial Peptides
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Expectorants
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Probiotics
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Oral Corticosteroids
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL DENTAL CARIES TREATMENT MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospitals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Dental Clinics
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. GLOBAL DENTAL CARIES TREATMENT MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Region, 2017 – 2023
9. NORTH AMERICA DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.1.1. Antimicrobial Peptides
9.1.1.2. Expectorants
9.1.1.3. Probiotics
9.1.1.4. Oral Corticosteroids
9.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Dental Restoration
9.1.2.1.1. Indirect Restoration
9.1.2.1.2. Direct Restoration
9.1.2.2. Dental Reconstruction
9.1.2.2.1. Dentures
9.1.2.2.2. Implants
9.1.2.2.3. Abutments
9.1.2.2.4. Crowns
9.1.2.2.5. Bridges
9.1.2.3. Endodontic
9.1.2.3.1. Permanent Sealers
9.1.2.3.2. Files
9.1.2.3.3. Obturator Devices
9.1.2.3.4. Others
9.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Hospitals
9.1.3.2. Dental Clinics
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
9.1.6. North America Dental Caries Treatment Market Dynamics – Trends
10. EUROPE DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.1.1. Antimicrobial Peptides
10.1.1.2. Expectorants
10.1.1.3. Probiotics
10.1.1.4. Oral Corticosteroids
10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Dental Restoration
10.1.2.1.1. Indirect Restoration
10.1.2.1.2. Direct Restoration
10.1.2.2. Dental Reconstruction
10.1.2.2.1. Dentures
10.1.2.2.2. Implants
10.1.2.2.3. Abutments
10.1.2.2.4. Crowns
10.1.2.2.5. Bridges
10.1.2.3. Endodontic
10.1.2.3.1. Permanent Sealers
10.1.2.3.2. Files
10.1.2.3.3. Obturator Devices
10.1.2.3.4. Others
10.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Hospitals
10.1.3.2. Dental Clinics
10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
10.1.6. Europe Dental Caries Treatment Market Dynamics – Trends
11. ASIA-PACIFIC DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1.1. Antimicrobial Peptides
11.1.1.2. Expectorants
11.1.1.3. Probiotics
11.1.1.4. Oral Corticosteroids
11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Dental Restoration
11.1.2.1.1. Indirect Restoration
11.1.2.1.2. Direct Restoration
11.1.2.2. Dental Reconstruction
11.1.2.2.1. Dentures
11.1.2.2.2. Implants
11.1.2.2.3. Abutments
11.1.2.2.4. Crowns
11.1.2.2.5. Bridges
11.1.2.3. Endodontic
11.1.2.3.1. Permanent Sealers
11.1.2.3.2. Files
11.1.2.3.3. Obturator Devices
11.1.2.3.4. Others
11.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Hospitals
11.1.3.2. Dental Clinics
11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
11.1.6. Asia-Pacific Dental Caries Treatment Market Dynamics – Trends
12. LATIN AMERICA DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1.1. Antimicrobial Peptides
12.1.1.2. Expectorants
12.1.1.3. Probiotics
12.1.1.4. Oral Corticosteroids
12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Dental Restoration
12.1.2.1.1. Indirect Restoration
12.1.2.1.2. Direct Restoration
12.1.2.2. Dental Reconstruction
12.1.2.2.1. Dentures
12.1.2.2.2. Implants
12.1.2.2.3. Abutments
12.1.2.2.4. Crowns
12.1.2.2.5. Bridges
12.1.2.3. Endodontic
12.1.2.3.1. Permanent Sealers
12.1.2.3.2. Files
12.1.2.3.3. Obturator Devices
12.1.2.3.4. Others
12.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Hospitals
12.1.3.2. Dental Clinics
12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
12.1.6. Latin America Dental Caries Treatment Market Dynamics – Trends
13. MIDDLE EAST & AFRICA DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1.1. Antimicrobial Peptides
13.1.1.2. Expectorants
13.1.1.3. Probiotics
13.1.1.4. Oral Corticosteroids
13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Dental Restoration
13.1.2.1.1. Indirect Restoration
13.1.2.1.2. Direct Restoration
13.1.2.2. Dental Reconstruction
13.1.2.2.1. Dentures
13.1.2.2.2. Implants
13.1.2.2.3. Abutments
13.1.2.2.4. Crowns
13.1.2.2.5. Bridges
13.1.2.3. Endodontic
13.1.2.3.1. Permanent Sealers
13.1.2.3.2. Files
13.1.2.3.3. Obturator Devices
13.1.2.3.4. Others
13.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Hospitals
13.1.3.2. Dental Clinics
13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
13.1.6. MEA Dental Caries Treatment Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Sanofi (France)
14.2.2. Abbott Laboratories (U.S.)
14.2.3. Bayer AG (Germany)
14.2.4. Eli Lilly and Company (U.S.)
14.2.5. Bristol-Myers Squibb (U.S.)
14.2.6. Merck & Co, Inc. (U.S.)
14.2.7. AstraZeneca Plc. (U.S.)
14.2.8. Dr.Reddy’s Lab (India)
14.2.9. Novartis AG. (Switzerland)
14.2.10. Dentsply Sirona Inc. (U.S.)
14.2.11. 3M Company (U.S.)
14.2.12. Danaher Corporation (U.S.)
14.2.13. Zimmer Inc., (U.S.)
14.2.14. Straumann AG (Switzerland)
14.2.15. Henry-Schein Inc. (U.S.)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL DENTAL CARIES TREATMENT MARKET INTRODUCTION
2.1. Global Dental Caries Treatment Market– Taxonomy
2.2. Global Dental Caries Treatment Market–Definitions
2.2.1. Product Type
2.2.2. Drug Class
3. GLOBAL DENTAL CARIES TREATMENT MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Dental Caries Treatment Market Dynamics – Factors Impact Analysis
3.6. Global Dental Caries Treatment Market– Recent Market Introductions
4. GLOBAL DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL DENTAL CARIES TREATMENT MARKET FORECAST, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. Dental Restoration
5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Dental Reconstruction
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Endodontic
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. GLOBAL DENTAL CARIES TREATMENT MARKET FORECAST, BY DRUG CLASS, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Antimicrobial Peptides
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Expectorants
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Probiotics
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Oral Corticosteroids
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. GLOBAL DENTAL CARIES TREATMENT MARKET FORECAST, BY END USER, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Hospitals
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Dental Clinics
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. GLOBAL DENTAL CARIES TREATMENT MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. North America
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Europe
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Latin America
8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
8.6. Global Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Region, 2017 – 2023
9. NORTH AMERICA DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.1.1. Antimicrobial Peptides
9.1.1.2. Expectorants
9.1.1.3. Probiotics
9.1.1.4. Oral Corticosteroids
9.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.2.1. Dental Restoration
9.1.2.1.1. Indirect Restoration
9.1.2.1.2. Direct Restoration
9.1.2.2. Dental Reconstruction
9.1.2.2.1. Dentures
9.1.2.2.2. Implants
9.1.2.2.3. Abutments
9.1.2.2.4. Crowns
9.1.2.2.5. Bridges
9.1.2.3. Endodontic
9.1.2.3.1. Permanent Sealers
9.1.2.3.2. Files
9.1.2.3.3. Obturator Devices
9.1.2.3.4. Others
9.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
9.1.3.1. Hospitals
9.1.3.2. Dental Clinics
9.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
9.1.4.1. U.S.
9.1.4.2. Canada
9.1.5. North America Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
9.1.6. North America Dental Caries Treatment Market Dynamics – Trends
10. EUROPE DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.1.1. Antimicrobial Peptides
10.1.1.2. Expectorants
10.1.1.3. Probiotics
10.1.1.4. Oral Corticosteroids
10.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Dental Restoration
10.1.2.1.1. Indirect Restoration
10.1.2.1.2. Direct Restoration
10.1.2.2. Dental Reconstruction
10.1.2.2.1. Dentures
10.1.2.2.2. Implants
10.1.2.2.3. Abutments
10.1.2.2.4. Crowns
10.1.2.2.5. Bridges
10.1.2.3. Endodontic
10.1.2.3.1. Permanent Sealers
10.1.2.3.2. Files
10.1.2.3.3. Obturator Devices
10.1.2.3.4. Others
10.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Hospitals
10.1.3.2. Dental Clinics
10.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. Germany
10.1.4.2. UK
10.1.4.3. France
10.1.4.4. Spain
10.1.4.5. Italy
10.1.4.6. Russia
10.1.4.7. Poland
10.1.4.8. Rest of Europe
10.1.5. Europe Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
10.1.6. Europe Dental Caries Treatment Market Dynamics – Trends
11. ASIA-PACIFIC DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.1.1. Antimicrobial Peptides
11.1.1.2. Expectorants
11.1.1.3. Probiotics
11.1.1.4. Oral Corticosteroids
11.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Dental Restoration
11.1.2.1.1. Indirect Restoration
11.1.2.1.2. Direct Restoration
11.1.2.2. Dental Reconstruction
11.1.2.2.1. Dentures
11.1.2.2.2. Implants
11.1.2.2.3. Abutments
11.1.2.2.4. Crowns
11.1.2.2.5. Bridges
11.1.2.3. Endodontic
11.1.2.3.1. Permanent Sealers
11.1.2.3.2. Files
11.1.2.3.3. Obturator Devices
11.1.2.3.4. Others
11.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Hospitals
11.1.3.2. Dental Clinics
11.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
11.1.4.1. Japan
11.1.4.2. China
11.1.4.3. India
11.1.4.4. ASEAN
11.1.4.5. Australia & New Zealand
11.1.4.6. Rest of Asia-Pacific
11.1.5. Asia-Pacific Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
11.1.6. Asia-Pacific Dental Caries Treatment Market Dynamics – Trends
12. LATIN AMERICA DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.1.1. Antimicrobial Peptides
12.1.1.2. Expectorants
12.1.1.3. Probiotics
12.1.1.4. Oral Corticosteroids
12.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Dental Restoration
12.1.2.1.1. Indirect Restoration
12.1.2.1.2. Direct Restoration
12.1.2.2. Dental Reconstruction
12.1.2.2.1. Dentures
12.1.2.2.2. Implants
12.1.2.2.3. Abutments
12.1.2.2.4. Crowns
12.1.2.2.5. Bridges
12.1.2.3. Endodontic
12.1.2.3.1. Permanent Sealers
12.1.2.3.2. Files
12.1.2.3.3. Obturator Devices
12.1.2.3.4. Others
12.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Hospitals
12.1.3.2. Dental Clinics
12.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.4.1. Brazil
12.1.4.2. Mexico
12.1.4.3. Argentina
12.1.4.4. Venezuela
12.1.4.5. Rest of Latin America
12.1.5. Latin America Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
12.1.6. Latin America Dental Caries Treatment Market Dynamics – Trends
13. MIDDLE EAST & AFRICA DENTAL CARIES TREATMENT MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1.1. Drug Class Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.1.1. Antimicrobial Peptides
13.1.1.2. Expectorants
13.1.1.3. Probiotics
13.1.1.4. Oral Corticosteroids
13.1.2. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Dental Restoration
13.1.2.1.1. Indirect Restoration
13.1.2.1.2. Direct Restoration
13.1.2.2. Dental Reconstruction
13.1.2.2.1. Dentures
13.1.2.2.2. Implants
13.1.2.2.3. Abutments
13.1.2.2.4. Crowns
13.1.2.2.5. Bridges
13.1.2.3. Endodontic
13.1.2.3.1. Permanent Sealers
13.1.2.3.2. Files
13.1.2.3.3. Obturator Devices
13.1.2.3.4. Others
13.1.3. End User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Hospitals
13.1.3.2. Dental Clinics
13.1.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.4.1. Gulf Cooperation Council (GCC) Countries
13.1.4.2. Israel
13.1.4.3. South Africa
13.1.4.4. Rest of MEA
13.1.5. MEA Dental Caries Treatment Market- Opportunity Analysis Index - By Drug Class, By Product Type, By End User, and Country, 2017 – 2023
13.1.6. MEA Dental Caries Treatment Market Dynamics – Trends
14. COMPETITION LANDSCAPE
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Sanofi (France)
14.2.2. Abbott Laboratories (U.S.)
14.2.3. Bayer AG (Germany)
14.2.4. Eli Lilly and Company (U.S.)
14.2.5. Bristol-Myers Squibb (U.S.)
14.2.6. Merck & Co, Inc. (U.S.)
14.2.7. AstraZeneca Plc. (U.S.)
14.2.8. Dr.Reddy’s Lab (India)
14.2.9. Novartis AG. (Switzerland)
14.2.10. Dentsply Sirona Inc. (U.S.)
14.2.11. 3M Company (U.S.)
14.2.12. Danaher Corporation (U.S.)
14.2.13. Zimmer Inc., (U.S.)
14.2.14. Straumann AG (Switzerland)
14.2.15. Henry-Schein Inc. (U.S.)
15. RESEARCH METHODOLOGY
16. KEY ASSUMPTIONS AND ACRONYMS
